Middleton & CO Inc Novo Nordisk A S Transaction History

Middleton & CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 01, 2019	SELL	$41.54 - $47.25 $833,084 - $947,598	-20,055 Closed	0 $0
Q2 2018 Jul 26, 2018	SELL	$44.29 - $50.42 $5,314 - $6,050	-120 Reduced 0.59%	20,055 $925,000
Q4 2017 Jan 25, 2018	SELL	$47.53 - $53.73 $118,825 - $134,325	-2,500 Reduced 11.03%	20,175 $1.08 Million
Q3 2017 Oct 31, 2017	BUY	$41.15 - $49.22 $933,076 - $1.12 Million	22,675	22,675 $1.09 Million

1,928

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $178B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Middleton & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Middleton & CO Inc with notifications on news.